Duplex pyrosequencing of the TPMT*3C and TPMT*6 alleles in Korean and Vietnamese populations

Clinica Chimica Acta

Volumn 398, Issue 1-2, 2008, Pages 82-85

  Lee, Sang Seop ^a   Kim, Woo Young ^a   Jang, Yin Jin ^a   Shin, Jae Gook ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Duplex pyrosequencing assay; Polymorphism; TPMT; Vietnamese

Indexed keywords

ALLELE; ARTICLE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; KOREA; POPULATION GENETICS; PRIORITY JOURNAL; PYROSEQUENCING; RELIABILITY; TPMT GENE; VIET NAM;

ALLELES; COST-BENEFIT ANALYSIS; DNA; GENE FREQUENCY; GENOTYPE; HUMANS; KOREA; METHYLTRANSFERASES; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; VIETNAM;

EID: 54049134371     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.08.014     Document Type: Article

References (26)

1. McLeod H.L., Krynetski E.Y., Relling M.V., and Evans W.E. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14 (2000) 567-572
2. Krynetski E.Y., and Evans W.E. Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance. Pharmacology 61 (2000) 136-146
3. Lindqvist M., Skoglund K., Karlgren A., et al. Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23. Pharmacogenet Genomics 17 (2007) 891-895
4. Schaeffeler E., Eichelbaum M., Reinisch W., Zanger U.M., and Schwab M. Three novel thiopurine S-methyltransferase allelic variants (TPMT*20, *21, *22) - association with decreased enzyme function. Human Mutat 27 (2006) 976
5. Hiratsuka M., Inoue T., Omori F., Agatsuma Y., and Mizugaki M. Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population. Mutat Res 448 (2000) 91-95
6. Chang J.G., Lee L.S., Chen C.M., et al. Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations. Pharmacogenetics 12 (2002) 191-195
7. Kham S.K., Soh C.K., Liu T.C., et al. Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol (2008)
8. Kham S.K., Tan P.L., Tay A.H., Heng C.K., Yeoh A.E., and Quah T.C. Thiopurine methyltransferase polymorphisms in a multiracial Asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 24 (2002) 353-359
9. Collie-Duguid E.S., Pritchard S.C., Powrie R.H., et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9 (1999) 37-42
10. Jun J.B., Cho D.Y., Kang C., and Bae S.C. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine. Clin Exp Rheumatol 23 (2005) 873-876
11. Fargher E.A., Tricker K., Newman W., et al. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. J Clin Pharm Ther 32 (2007) 187-195
12. Spire-Vayron de la Moureyre C., Debuysere H., Sabbagh N., et al. Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Human Mutat 12 (1998) 177-185
13. Schaeffeler E., Lang T., Zanger U.M., Eichelbaum M., and Schwab M. High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC. Clin Chem 47 (2001) 548-555
14. Otterness D., Szumlanski C., Lennard L., et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 62 (1997) 60-73
15. Schutz E., von Ahsen N., and Oellerich M. Genotyping of eight thiopurine methyltransferase mutations: three-color multiplexing, "two-color/shared" anchor, and fluorescence-quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design. Clin Chem 46 (2000) 1728-1737
16. Haglund S., Lindqvist M., Almer S., Peterson C., and Taipalensuu J. Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin Chem 50 (2004) 288-295
17. Lindqvist M., Haglund S., Almer S., et al. Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity. Pharmacogenetics 14 (2004) 261-265
18. Okada Y., Nakamura K., Wada M., et al. Genotyping of thiopurine methyltransferase using pyrosequencing. Biol Pharm Bull 28 (2005) 677-681
19. Watters J.W., Zhang W., Meucci M.A., Hou W., Ma M.K., and McLeod H.L. Analysis of variation in mouse TPMT genotype, expression and activity. Pharmacogenetics 14 (2004) 247-254
20. Nasedkina T.V., Fedorova O.E., Glotov A.S., et al. Rapid genotyping of common deficient thiopurine S-methyltransferase alleles using the DNA-microchip technique. Eur J Hum Genet 14 (2006) 991-998
21. Lee S.S., Jeong H.E., Liu K.H., et al. Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity. Pharmacogenet Genom 15 (2005) 105-113
22. Lee S.S., Kim S.Y., Kim W.Y., et al. MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles in Korean and Vietnamese populations. Ther Drug Monit 27 (2005) 531-535
23. Lee S.S., Lee S.J., Gwak J., et al. Comparisons of CYP2C19 genetic polymorphisms between Korean and Vietnamese populations. Ther Drug Monit 29 (2007) 455-459
24. Veenstra D.L., Higashi M.K., and Phillips K.A. Assessing the cost-effectiveness of pharmacogenomics. AAPS PharmSci 2 (2000) E29
25. Srimartpirom S., Tassaneeyakul W., and Kukongviriyapan V. Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Br J Clin Pharmacol 58 (2004) 66-70
26. Kumagai K., Hiyama K., Ishioka S., et al. Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese. Pharmacogen 11 (2001) 275-278